The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... and more accurate clinical trial periods. More data and faster analysis mean ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Interest in artificial intelligence (AI) as a tool to help find new drugs has exploded in recent years and it could help accelerate and reduce the cost of ... stages of drug development, says ...

The average drug ... in drug development,” he adds. “The utilization of AI and big data is revolutionizing our drug-discovery process. What once required many years and enormous costs is ...

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Pharma major Roche may have earned over a hundred times what risdiplam, a drug used to treat spinal muscular atrophy (SMA), ...

In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...